Loading...
Loading...
Rochester medical device startup developing the FDA-cleared Capnospot pneumothorax decompression indicator. Technology developed at Mayo Clinic, 2023 EMS World Innovation Award winner.
Pneumeric, Inc. is a medical device company aimed at improving care for those affected by pneumothorax (collapsed lung). The technology was developed at Mayo Clinic in Rochester, MN. In March 2023, Pneumeric received FDA clearance for their Capnospot device. The Capnospot® Pneumothorax Decompression Indicator is transforming the standard of care in needle decompression from "a gush of air" to a straightforward color change. Capnospot is a small, lightweight, portable device designed to affix on the distal end of any commercially available needle used for decompression. It provides objective, visual confirmation of successful needle decompression. The device is primarily used by emergency medical services and military medical personnel. The Capnospot device received a 2023 EMS World Innovation Award for its visual confirmation of tension pneumothorax decompression success.
Community feedback
No approved reviews yet. Be the first to share your experience.
Please log in to share your experience.